Sponsor:
Oregon Health and Science University
Code:
NCT02141308
Conditions
Retinal Artery Occlusions
Polypoidal Choroidal Vasculopathy
Retinal Arterial Macroaneurysm
Juxtafoveal Telangiecasia
Central Serous Chorioretinopathy
Eligibility Criteria
Sex: All
Age: 7 - 70+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Retinal Artery Occlusions
Polypoidal Choroidal Vasculopathy
Retinal Arterial Macroaneurysm
Juxtafoveal Telangiecasia
Central Serous Chorioretinopathy
Study ID
NCT02141308
Start date
May, 2014
Status verified date
Feb, 2024
Completion date
Dec, 2026
Anticipated
Primary completion date
Dec, 2025
Anticipated
Eligibility Criteria
Sex: All
Age: 7 - 70+
Healthy Volunteers: Not accepted
Enrollment
150 participants
Anticipated
Arms
Rare Chorioretinal Disease
Primary outcome measure
Central contacts
Locations
Casey Eye Institute, Oregon Health & Science University
Recruiting
Portland, Oregon, United States, 97239-3098
Contacts
Sponsor
Oregon Health and Science University
Last update posted
Feb 12, 2024
Last verified
Feb, 2024
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Oregon Health and Science University on 2024-02-12.